A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Baseline Choroidal Blood Flow Imbalance as a Predictive Factor for Macular Edema Recurrence Secondary to Branch Retinal Vein Occlusion. | LitMetric

AI Article Synopsis

  • This study assesses how choroidal blood flow (CBF) and choroidal thickness (CT) can predict if macular edema will return in patients with a specific type of eye condition (BRVO) after receiving treatment.
  • Sixteen patients were treated with an injection and monitored for changes in CBF and CT over a year using specialized imaging techniques.
  • Results showed that thicker CT in affected areas initially dropped after one week, while CBF remained steady; however, an imbalance in CBF was linked to how many injections were later needed, suggesting it could help predict recurrence of macular edema.

Article Abstract

Background/objectives: To evaluate the roles of choroidal blood flow (CBF) and choroidal thickness (CT) as predictors of macular edema recurrence in patients with treatment-naive non-ischemic branch retinal vein occlusion (BRVO) after intravitreal ranibizumab (IVR) injection.

Methods: Sixteen eyes from sixteen patients with treatment-naive non-ischemic BRVO treated with IVR, once initially and then as needed, were included in the study. CBF and CT in the subfovea, occlusive, and non-occlusive regions were measured via laser speckle flowgraphy and enhanced depth imaging optical coherence tomography over 12 months.

Results: Baseline CT was significantly greater in the occlusive region (335 ± 72.1 µm) than in the non-occlusive region (274 ± 36.7 µm, = 0.028). CT in the occlusive region was reduced significantly after 1 week ( = 0.008), but CBF did not change significantly after IVR throughout the follow-up period ( > 0.05). The occlusive/non-occlusive region CBF ratio at baseline was significantly associated with the number of IVR injections over 12 months (mean 2.63) in patients with BRVO ( = 0.048).

Conclusions: Baseline CBF imbalance in eyes with treatment-naive BRVO may indicate the recurrence of macular edema after ranibizumab therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11507006PMC
http://dx.doi.org/10.3390/diagnostics14202328DOI Listing

Publication Analysis

Top Keywords

macular edema
12
choroidal blood
8
blood flow
8
edema recurrence
8
branch retinal
8
retinal vein
8
vein occlusion
8
patients treatment-naive
8
treatment-naive non-ischemic
8
occlusive region
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!